RGD peptides (BMS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRGD peptides (BMS)
Drug Alias Namecyclo-RGDRGdRGD peptides (DuPont)RGDRGD
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Pharma Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma CompanyBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A